Complex treatment of ankylosing spondylitis in combination with bioresonance therapy
AUTHORS : Khachumova K.G. | Lytkina K.A.
RELEVANT UNIVERSITIES : Russian State Medical University, Moscow, Russia
YEAR : 2008
Ankylosing spondylitis (AS) is the main form of inflammatory diseases of the spine. AS is characterized by a
chronic progressive course and leads to ankylosis of the ileosacral and intervertebral joints, calcification of the
spinal ligaments and limited mobility of the spine. AS usually begins at a young age. The average age of onset of
this disease is 24 years [1]. The prevalence of AS is associated with the frequency of occurrence of HLA-B27 and
varies widely – from 0.15% in Finland, to 1.4% in Norway, and even up to 2.5% among the adult population of
Alaska Eskimos, but in general it is 1: 200 the adult population, i.e. 0.05% [2]. According to Ward MM [4], the low
quality of life is explained by the pronounced stiffness observed in this disease, in 90% of patients, pain (83%),
increased fatigue (62%),
